Human amniotic epithelial stem cells（hAESCs）
NFEC-2019-128
Phase 1 mab terminated
Quick answer
Human amniotic epithelial stem cells（hAESCs） for Acute Graft Versus Host Disease is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Acute Graft Versus Host Disease
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated